Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Joanna Drzewinska"'
Autor:
Amelia Chyb, Radosław Włodarczyk, Joanna Drzewińska‐Chańko, Jan Jedlikowski, Kimberly K. O. Walden, Piotr Minias
Publikováno v:
Ecology and Evolution, Vol 13, Iss 10, Pp n/a-n/a (2023)
Abstract Extensive transformation of natural land cover into urbanized areas enhances accumulation of phenotypic differences between animals from urban and nonurban populations, but there is little information on whether these changes, especially in
Externí odkaz:
https://doaj.org/article/4abe2f8094894af3bf595c98b20bc023
Autor:
Piotr Minias, Kamila Gach, Radosław Włodarczyk, Maciej Bartos, Joanna Drzewińska-Chańko, Miłosz Rembowski, Dariusz Jakubas, Tomasz Janiszewski
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241602 (2020)
The choice of colony size may have profound consequences for individual fitness in colonially breeding birds, but at the same time it may require certain behavioural adaptations. Here, we aimed to examine behavioural divergence of common terns Sterna
Externí odkaz:
https://doaj.org/article/33fc6accd89f475796681c14875b8a2e
Autor:
Grzegorz Bartosz, Łukasz Pułaski, Joanna Drzewinska, Łukasz Piotrowski, Milan Stefek, Aneta Balcerczyk
Publikováno v:
Interdisciplinary Toxicology, Vol 7, Iss 1, Pp 27-32 (2014)
Interdisciplinary Toxicology
Interdisciplinary Toxicology
The aim of the study was to evaluate the antioxidant action of SMe1EC2, the structural analogue of the hexahydropyridoindole antioxidant stobadine. The antiradical activity of SMe1EC2 was found to be higher when compared to stobadine, as determined b
Publikováno v:
Biochemical and Biophysical Research Communications. 427:197-201
The antisense oligonucleotides are promising agents for application in anti-HIV therapies. The antiretroviral nucleoside analogues administrated into circulatory system are vulnerable to nuclease degradation and require a vehicle which would not only
Publikováno v:
Molecular Biology Reports. 38:1091-1101
Mutations in the DHCR24 gene, which encodes the cholesterol biosynthesis enzyme 3ß-hydroxysterol-∆24 reductase, result in an autosomal recessive disease called desmosterolosis. Further, reduced expression of DHCR24 is found in the temporal cortex
Autor:
Dzmitry Shcharbin, Dietmar Appelhans, Michal Szewczyk, Joanna Drzewinska, Maria Bryszewska, Barbara Klajnert, Dzmitruk
Publikováno v:
The journal of physical chemistry. B. 116(50)
There are several barriers to the application of dendriplexes formed by poly(propylene imine) dendrimers and genetic material for gene therapy. One limitation is their interaction with extracellular matrix components such as glucosaminoglycans. These
Autor:
Justyna Zapart-Bukowska, Michał Śmigielski, Olgierd Smoleński, Łukasz R. Nowak, Jan Kulpa, K Duda, Joanna Drzewinska, Joanna Majerczak, Jerzy A. Zoladz, Grzegorz Bartosz
Publikováno v:
Neurochemical research. 37(12)
In the present study we have evaluated the effect of a single hemodialysis session on the brain-derived neurotrophic factor levels in plasma [BDNF](pl) and in serum [BDNF](s) as well as on the plasma isoprostanes concentration [F(2) isoprostanes](pl)
Autor:
Wojciech Łuczaj, Giuseppe Poli, Martina Podborska, Cinzia Mascia, Nicolle Breusing, Corinne M. Spickett, Norsyahida Mohd Fauzi, Ingrid Wiswedel, Tilman Grune, Maria Cristina Munteanu, Anca Dinischiotu, Rosario Casillas, Daniela Gradinaru, Sieglinde Zelzer, Antonín Lojek, Laura Bravo, Suzana Borović, Maria Teresa Mitjavila, Neven Zarkovic, Fiorella Biasi, Juan Gambini, Heidemarie Faber, Lidija Mrakovcic, Grzegorz Bartosz, Isidre Casals, Raquel Mateos, Luka Andrisic, Elżbieta Skrzydlewska, Jose Viña, Andreas Meinitzer, Paulina Sicinska, Joanna Drzewinska, Mustafa Atalay, Agnieszka Gajewska, Denisa Margina, Tarja Kokkola
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Lipid peroxidation products like malondialdehyde, 4-hydroxynonenal and F2-isoprostanes are widely used as markers of oxidative stress in vitro and in vivo. This study reports the results of a multi-laboratory validation study by COST Action B35 to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e61b282bb80de03ec4c46053739d959f
https://doi.org/10.3109/10715762.2010.499907
https://doi.org/10.3109/10715762.2010.499907
Autor:
Machnicki M Marcin, Joanna Barankiewicz, Anna Deregowska, Joanna Drzewinska-Chanko, Pruszczyk Katarzyna, Maciej Wnuk, Tomasz Stoklosa
Publikováno v:
Blood. 124:5510-5510
Introduction of tyrosine kinase inhibitors (TKI) to the therapy of chronic myeloid leukemia (CML) remains one of the most remarkable achievements in oncology. Five TKI are currently approved to treat patients with CML. While imatinib revolutionized t